A Phase 3, Randomized, Double-Blind, Placebo-Controlled,

Project: Research project

Project Details

Description

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects with Active Crohn's Disease
StatusFinished
Effective start/end date2/21/173/22/18

Funding

  • Celgene Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.